Renaissance Technologies (RenTech)'s GLUE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 379,100 shares of Monte Rosa Therapeutics, Inc. (GLUE) worth $6.24 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in GLUE, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 451,000 shares. Largest reduction occurred in Q4 2025, reducing 395,733 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Monte Rosa Therapeutics (GLUE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Monte Rosa Therapeutics (GLUE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +379,100 | New Buy | 379,100 | $16.45 |
| Q4 2025 | -395,733 | Sold Out | 0 | $0.00 |
| Q3 2025 | -219,367 | Reduce 35.66% | 395,733 | $7.41 |
| Q2 2025 | +451,000 | Add 274.83% | 615,100 | $4.51 |
| Q1 2025 | -81,600 | Reduce 33.21% | 164,100 | $4.64 |
| Q4 2024 | +27,000 | Add 12.35% | 245,700 | $6.94 |
| Q3 2024 | -36,014 | Reduce 14.14% | 218,700 | $5.30 |
| Q2 2024 | +132,614 | Add 108.61% | 254,714 | $3.74 |
| Q1 2024 | +16,900 | Add 16.06% | 122,100 | $7.05 |
| Q4 2023 | +13,700 | Add 14.97% | 105,200 | $5.65 |
| Q3 2023 | +9,700 | Add 11.86% | 91,500 | $4.79 |
| Q2 2023 | +53,900 | Add 193.19% | 81,800 | $0.01 |
| Q1 2023 | +11,500 | Add 70.12% | 27,900 | $0.01 |
| Q4 2022 | +16,400 | New Buy | 16,400 | $0.01 |
Renaissance Technologies (RenTech)'s Monte Rosa Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Monte Rosa Therapeutics, Inc. (GLUE) in Q4 2022, acquiring 16,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Monte Rosa Therapeutics, Inc. (GLUE) for 14 quarters since Q4 2022.
Renaissance Technologies (RenTech)'s largest addition to Monte Rosa Therapeutics, Inc. (GLUE) was in Q2 2025, adding 615,100 shares worth $2.77 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 379,100 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $6.24 M.
As of the Q1 2026 filing, Monte Rosa Therapeutics, Inc. (GLUE) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Monte Rosa Therapeutics, Inc. (GLUE) was 615,100 shares, as reported at the end of Q2 2025.